A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer

Metastatic colorectal cancer is the fourth most common cause of death due to cancer after those of lung, stomach, and liver. Anti epidermal growth factor receptor drugs as a targeting therapy seem to be good candidates for curing metastatic colorectal cancer. Two available anti epidermal growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazdi, Mohammad Hossein, Faramarzi, Mohammad Ali, Nikfar, Shekoufeh, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629455/
https://www.ncbi.nlm.nih.gov/pubmed/26605007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629455/
https://www.ncbi.nlm.nih.gov/pubmed/26605007

Ejemplares similares